As of 2024-12-12, the Relative Valuation of TME Pharma NV (ALTME.PA) is - EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 EUR, the upside of TME Pharma NV based on Relative Valuation is -.
The range of the Relative Valuation is - EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-11-20 | -0.96 |
| 2024-11-19 | -0.97 |
| 2024-11-18 | -0.99 |
| 2024-11-15 | -0.99 |
| 2024-11-14 | -0.98 |
| 2024-11-13 | -0.95 |
| 2024-11-12 | -0.86 |
| 2024-11-11 | -0.97 |
| 2024-11-08 | -1.02 |
| 2024-11-07 | -0.95 |
| 2024-11-06 | -0.93 |
| 2024-11-05 | -0.95 |
| 2024-11-04 | -0.97 |
| 2024-11-01 | -1.05 |
| 2024-10-31 | -1.07 |
| 2024-10-30 | -0.99 |
| 2024-10-29 | -0.97 |
| 2024-10-28 | -0.92 |
| 2024-10-25 | -0.91 |
| 2024-10-24 | -0.88 |
| 2024-10-23 | -0.90 |
| 2024-10-22 | -0.92 |
| 2024-10-21 | -0.92 |
| 2024-10-18 | -0.86 |
| 2024-10-17 | -0.85 |
| 2024-10-16 | -0.82 |
| 2024-10-15 | -0.81 |
| 2024-10-14 | -0.90 |
| 2024-10-11 | -0.87 |
| 2024-10-10 | -0.83 |
| 2024-10-09 | -0.82 |
| 2024-10-08 | -0.82 |
| 2024-10-07 | -0.79 |
| 2024-10-04 | -0.83 |
| 2024-10-03 | -0.80 |
| 2024-10-02 | -0.81 |
| 2024-10-01 | -0.82 |
| 2024-09-30 | -0.90 |
| 2024-09-27 | -0.90 |
| 2024-09-26 | -0.92 |
| 2024-09-25 | -0.92 |
| 2024-09-24 | -0.93 |
| 2024-09-23 | -0.88 |
| 2024-09-20 | -0.90 |
| 2024-09-19 | -0.95 |
| 2024-09-18 | -1.00 |
| 2024-09-17 | -1.03 |
| 2024-09-16 | -1.03 |
| 2024-09-13 | -0.90 |
| 2024-09-12 | -0.92 |